TB Diagnostic Market Report 2024 (Global Edition)

Global TB Diagnostic Market Report 2024 Market Size Split by Test Type (Nucleic Acid Testing, Detection of Drug Resistance (DST), Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, ...

TB Diagnostic Market Report Description

We have various report editions of TB Diagnostic Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

TB Diagnostic Market Insights Video

Competitive Landscape of the TB Diagnostic Market

A wide variety of businesses and organizations involved in creating and offering diagnostic solutions define the competitive landscape of the TB diagnostic market. Many businesses are focusing on developing nations like Africa, Southeast Asia, and India that have high rates of tuberculosis. This includes initiatives to offer accessible and reasonably priced diagnostic options in environments with limited resources. Furthermore, businesses must navigate intricate regulatory frameworks to obtain approval for novel diagnostic products. Adherence to both global and regional norms is essential for both entering and growing markets.

February 2023: To improve laboratory capacities in nations heavily impacted by the HIV and tuberculosis (TB) epidemics, Roche stated that it will be expanding its partnership with the U.S. Centers for Disease Control and Prevention (CDC). In a few chosen nations in Africa, Eastern Europe, Central Asia, and the Western Hemisphere (such as Latin America, Central America, and the Caribbean), Roche and the CDC will work to enhance HIV and tuberculosis prevention, detection, and treatment outcomes through the implementation of a public-private partnership (PPP) called "Lab Networks for Health”. (Source: https://diagnostics.roche.com/us/en/news-listing/2023/roche-joins-cdc-strengthen-labs-fight-against-hiv-tuberculosis.html) April 2024: Revvity, Inc. declared the availability of Allsheng's Auto-Pure 2400 liquid handler for the T-SPOT.TB test. The Auto-Pure 2400 platform offers efficient lab procedures and is simple to use. The T-SPOT.TB test's accuracy and the Auto-Pure 2400 system's efficiency come together to create a potent solution that benefits labs, physicians, and patients in the end. (Source: https://news.revvity.com/press-announcements/press-releases/press-release-details/2024/Revvity-Unveils-a-New-Era-of-Automated-Tuberculosis-Testing/default.aspx)

Top Companies Market Share in TB Diagnostic Industry: (In no particular order of Rank)

• Danaher Corporation
• Molbio Diagnostics Pvt. Ltd.
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories
• Inc.
• bioMerieux SA
• Hologic Inc.
• F. Hoffmann-La Roche Ltd.
• Qiagen NV.
• Becton Dickinson & Company
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the TB Diagnostic Market

Which Region Dominates the TB Diagnostic Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. The growing regional market can be attributed to the increasing demand for advanced healthcare services, including the use of technology and novel testing for diagnosis, treatment, care, rehabilitation, and overall healthcare improvement. Increased research and development expenditures for improved tuberculosis diagnostics are anticipated to help the tuberculosis diagnostics market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the TB Diagnostic market. Screening efforts have increased as a result of greater awareness of tuberculosis (TB) and the significance of early detection. Large-scale screening initiatives are being carried out by NGOs and governments, especially in high-risk communities.

The current report Scope analyzes TB Diagnostic Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America TB Diagnostic Market

According to Cognitive Market Research, the global TB Diagnostic market size was estimated at USD 2251.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 900.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the TB Diagnostic market with a market size of USD 710.60 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The nation's presence of major players.
• The Canada TB Diagnostic market had a market share of USD 108.08 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Canada's increasing investment.
• The Mexico TB Diagnostic market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 81.96 million in 2024.

Europe TB Diagnostic Market

According to Cognitive Market Research, the global TB Diagnostic market size was estimated at USD 2251.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 675.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

• The United Kingdom TB Diagnostic market had a market share of USD 113.48 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. In the UK, TB Diagnostic sales witnessed an upswing due to the nation's rising product innovation.
• The France TB Diagnostic market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 62.14 million in 2024.
• According to Cognitive Market Research, the German TB Diagnostic market size was valued at USD 133.75 million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. In Germany, TB Diagnostic surged due to the presence of a supportive regulatory environment.
• The Italy TB Diagnostic market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 58.09 million in 2024.
• The Russia TB Diagnostic market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 104.70 million in 2024.
• The Spain TB Diagnostic market is projected to witness growth at a CAGR of 3.6% during the forecast period with a market size of USD 55.39 million in 2024
• The Luxembourg TB Diagnostic market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 20.94 million in 2024.
• The Portugal TB Diagnostic market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 14.19 million in 2024.
• The Greece TB Diagnostic market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 8.11 million in 2024.
• Rest of Europe's TB Diagnostic market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 104.70 million in 2024.

Asia Pacific TB Diagnostic Market

{asia_pacific_start}

According to Cognitive Market Research, the global TB Diagnostic market size was estimated at USD 2251.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 517.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.

• According to Cognitive Market Research, the China TB Diagnostic market size was valued at USD 233.04 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. TB Diagnostic surged in China due to the adoption of advanced technology.
• The Japan TB Diagnostic market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 71.47 million in 2024.
• The India TB Diagnostic market had a market share of USD 62.14 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. India's growing geriatric population.
• The South Korean TB Diagnostic market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 51.79 million in 2024.
• The Australian TB Diagnostic market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 26.93 million in 2024.
• The South East Asia TB Diagnostic market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 35.73 million in 2024.
• The Rest of Asia Pacific TB Diagnostic market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 36.77 million in 2024.

South America TB Diagnostic Market

According to Cognitive Market Research, the global TB Diagnostic market size was estimated at USD 2251.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 112.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil TB Diagnostic market size was valued at USD 48.18 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. TB Diagnostic flourished in Brazil due to product innovation.
• Argentina's TB Diagnostic market had a market share of USD 18.91 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. Argentina's rising investment.
• Colombia TB Diagnostic market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 10.02 million in 2024.
• Peru TB Diagnostic market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 9.23 million in 2024.
• Chile TB Diagnostic market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 8.11 million in 2024.
• The Rest of Latin America's TB Diagnostic market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 18.13 million in 2024.

Middle East and Africa TB Diagnostic Market

According to Cognitive Market Research, the global TB Diagnostic market size was estimated at USD 2251.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 45.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031..

• The GCC Countries TB Diagnostic market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 19.27 million in 2024. TB Diagnostic sales flourish due to the presence of major market players.
• The Egypt TB Diagnostic market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 4.73 million in 2024.
• The South Africa TB Diagnostic market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 7.12 million in 2024. TB Diagnostic sales flourish in South Africa due to technological advancements, increasing demand, and regulatory support.
• The Turkey TB Diagnostic market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 3.87 million in 2024.
• The Nigeria TB Diagnostic market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 4.73 million in 2024.
• The Rest of MEA TB Diagnostic market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 5.31 million in 2024.

TB Diagnostic Market Analysis

TB Diagnostic Market Test Type Segment Analysis

According to Cognitive Market Research, Nucleic Acid Testing stands out as the dominant category over the projected period. This growth is driven by the increasing adoption of molecular diagnostic techniques that rely on nucleic acid amplification, such as PCR (Polymerase Chain Reaction), to provide rapid and precise results.

Detection of Drug Resistance (DST) emerges as the fastest-growing category in the TB Diagnostic market. The Mycobacterium tuberculosis (TB) bacteria that is infecting a patient is defeated by certain drugs, as determined by DST. When treating multidrug-resistant and extensively drug-resistant tuberculosis, it detects resistance to both first- and second-line medications (isoniazid, rifampicin, ethambutol, and pyrazinamide). Treatment choices are made with the patient's drug susceptibility profile in mind thanks to the guidance provided by DST. This is essential to enhance treatment results, stop the development of new drug resistance, and stop the spread of resistant tuberculosis strains.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of TB Diagnostic Industry. Request a Free Sample PDF!

TB Diagnostic Market End Use Segment Analysis

According to Cognitive Market Research, the dominant category is Diagnostic Laboratories. The segment's expansion can be attributed to initiatives aimed at enhancing patient outcomes by offering diagnostic services at the retail level. Advanced blood tests are being introduced by diagnostic laboratories to aid in screening and detection.

The fastest-growing category in the TB Diagnostic market is Hospitals & Clinics. People who suffer from illnesses like HIV/AIDS, chronic kidney failure, and other immune-suppressive diseases are more vulnerable to tuberculosis. It is expected that the rising number of immune-related illnesses will increase testing rates in medical institutions, such as clinics and hospitals.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion